ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736116 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736116; 2) Community: the network communities that were significantly associated with the response to NSC 736116; 3) Molecule: the relationships between components within communities and NSC 736116; 4) MDR: the compounds that were significantly associated with the NSC 736116.

NSC Compound Enrichment Correlation
NSC 709974 Null 0.043472147060915 0.40401566
NSC 710326 Null 0.043472147060915 0.35667367
NSC 718781 Erlotinib hydrochloride 0.043472147060915 -0.1255645
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.043472147060915 0.3153581
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.043472147060915 -0.14590768
NSC 725098 Null 0.043472147060915 0.32255781
NSC 726217 Combretastatin A4-analogue 0.043472147060915 0.32992622
NSC 728078 2-carboxy-(2'-furyl)-7-chloro-3-trifluoromethylquinoxaline 1,4-dioxide 0.043472147060915 0.43614704
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.043472147060915 -0.0030787371
NSC 731704 1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. 0.043472147060915 0.22052283
Total:87  Current:67    [First] [Prev] [Next] [Last]